{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:00:08Z","timestamp":1780542008053,"version":"3.54.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018847","name":"Sel\u00e7uk University Research Foundation","doi-asserted-by":"publisher","award":["23122049"],"award-info":[{"award-number":["23122049"]}],"id":[{"id":"10.13039\/501100018847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00406-025-02190-x","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:56:17Z","timestamp":1767610577000},"page":"1661-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between neuronal pentraxin 2, ADHD symptoms, and executive functioning in adults with ADHD: a case-control study"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-7511","authenticated-orcid":false,"given":"Samet","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7861-258X","authenticated-orcid":false,"given":"Ramazan","family":"Kocaba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6563-3058","authenticated-orcid":false,"given":"Bilal","family":"Sa\u011fl\u0131yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9847-7082","authenticated-orcid":false,"given":"\u00d6mer","family":"Bay\u0131rl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2241-8171","authenticated-orcid":false,"given":"Ahmet Emre","family":"Yorulmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6940-0940","authenticated-orcid":false,"given":"Ali","family":"Kande\u011fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"2190_CR1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","volume":"128","author":"SV Faraone","year":"2021","unstructured":"Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA et al (2021) The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev 128:789\u2013818","journal-title":"Neurosci Biobehav Rev"},{"key":"2190_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.eurpsy.2018.11.001","volume":"56","author":"J Kooij","year":"2019","unstructured":"Kooij J, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balazs J et al (2019) Updated European consensus statement on diagnosis and treatment of adult ADHD. Eur Psychiatry 56:14\u201334","journal-title":"Eur Psychiatry"},{"key":"2190_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12402-016-0208-3","volume":"9","author":"J Fayyad","year":"2017","unstructured":"Fayyad J, Sampson NA, Hwang I, Adamowski T, Aguilar-Gaxiola S, Al-Hamzawi A et al (2017) The descriptive epidemiology of DSM-IV adult ADHD in the world health organization world mental health surveys. ADHD Attention Deficit and Hyperactivity Disorders 9:47\u201365","journal-title":"ADHD Attention Deficit and Hyperactivity Disorders"},{"key":"2190_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1060028013510699","volume":"48","author":"A Sharma","year":"2014","unstructured":"Sharma A, Couture J (2014) A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 48:209\u2013225","journal-title":"Ann Pharmacother"},{"key":"2190_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0149-7634(99)00062-7","volume":"24","author":"JM Swanson","year":"2000","unstructured":"Swanson JM, Flodman P, Kennedy J, Spence MA, Moyzis R, Schuck S et al (2000) Dopamine genes and ADHD. Neurosci Biobehav Rev 24:21\u201325","journal-title":"Neurosci Biobehav Rev"},{"key":"2190_CR6","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","volume":"160","author":"ND Volkow","year":"2003","unstructured":"Volkow ND, Swanson JM (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160:1909\u20131918","journal-title":"Am J Psychiatry"},{"key":"2190_CR7","doi-asserted-by":"publisher","unstructured":"Miller EM, Thomas TC, Gerhardt GA, Glaser PE (2013) Dopamine and glutamate interactions in ADHD: implications for the future neuropharmacology of ADHD. Attention deficit hyperactivity disorder in children and adolescents. IntechOpen. https:\/\/doi.org\/10.5772\/54207","DOI":"10.5772\/54207"},{"key":"2190_CR8","doi-asserted-by":"publisher","first-page":"101838","DOI":"10.1016\/j.arr.2023.101838","volume":"85","author":"P Chakraborty","year":"2023","unstructured":"Chakraborty P, Dey A, Gopalakrishnan AV, Swati K, Ojha S, Prakash A et al (2023) Glutamatergic neurotransmission: a potential pharmacotherapeutic target for the treatment of cognitive disorders. Ageing Res Rev 85:101838. https:\/\/doi.org\/10.1016\/j.arr.2023.101838","journal-title":"Ageing Res Rev"},{"key":"2190_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00406-022-01397-6","volume":"272","author":"MV Vidor","year":"2022","unstructured":"Vidor MV, Panzenhagen AC, Martins AR, Cupertino RB, Bandeira CE, Picon FA et al (2022) Emerging findings of glutamate\u2013glutamine imbalance in the medial prefrontal cortex in attention deficit\/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies. Eur Arch Psychiatry Clin Neurosci 272:1395\u20131411","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2190_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.9758\/cpn.23.1056","volume":"22","author":"E Ulu","year":"2023","unstructured":"Ulu E, Demirci E, Sener EF, \u00d6zmen S, Gul MK, Tahtasakal R et al (2023) Role of glutamate receptor-related biomarkers in the etiopathogenesis of ADHD. Clin Psychopharmacol Neurosci 22:79\u201386","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2190_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","volume":"129","author":"N de G\u00f3mez","year":"2022","unstructured":"de G\u00f3mez N, Massa F, Halbgebauer S, Oeckl P, Steinacker P, Otto M (2022) Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration. J Neural Transm 129:207\u2013230","journal-title":"J Neural Transm"},{"key":"2190_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00213-023-06515-3","volume":"241","author":"J Zhou","year":"2024","unstructured":"Zhou J, Li X, Wang X, Yang Y, Nai A, Shi H et al (2024) Levels of neuronal pentraxin 2 in plasma is associated with cognitive function in patients with schizophrenia. Psychopharmacology 241:865\u2013874","journal-title":"Psychopharmacology"},{"key":"2190_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fncel.2019.00575","volume":"13","author":"G Chapman","year":"2020","unstructured":"Chapman G, Shanmugalingam U, Smith PD (2020) The role of neuronal pentraxin 2 (NP2) in regulating glutamatergic signaling and neuropathology. Front Cell Neurosci 13:575","journal-title":"Front Cell Neurosci"},{"key":"2190_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.neuron.2015.02.020","volume":"85","author":"KA Pelkey","year":"2015","unstructured":"Pelkey KA, Barksdale E, Craig MT, Yuan X, Sukumaran M, Vargish GA et al (2015) Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons. Neuron 85:1257\u20131272","journal-title":"Neuron"},{"key":"2190_CR15","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1007\/s00213-022-06147-z","volume":"239","author":"D G\u00f6verti","year":"2022","unstructured":"G\u00f6verti D, B\u00fcy\u00fckl\u00fco\u011flu N, Kaya H, Y\u00fcksel RN, Y\u00fccel \u00c7, G\u00f6ka E (2022) Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophrenia. Psychopharmacology 239:2585\u20132591","journal-title":"Psychopharmacology"},{"key":"2190_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf0141","volume":"15","author":"J Zhou","year":"2023","unstructured":"Zhou J, Wade SD, Graykowski D, Xiao MF, Zhao B, Giannini LA et al (2023) The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration. Sci Transl Med 15:eadf0141","journal-title":"Sci Transl Med"},{"key":"2190_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2019.05.005","volume":"182","author":"GA Dunn","year":"2019","unstructured":"Dunn GA, Nigg JT, Sullivan EL (2019) Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav 182:22\u201334","journal-title":"Pharmacol Biochem Behav"},{"key":"2190_CR18","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Gonz\u00e1lez D, Carre\u00f3n-Trujillo S, Alvarez-Arellano L, Abarca-Merlin DM, Dom\u00ednguez-L\u00f3pez P, Salazar-Garc\u00eda M et al (2023) A potential role for neuroinflammation in ADHD. Neuroinflammation Gut Brain Axis Immun Neuropsychiatr Disord 411:327\u2013356","DOI":"10.1007\/978-981-19-7376-5_15"},{"key":"2190_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neurobiolaging.2025.09.002","volume":"156","author":"CL Anderson","year":"2025","unstructured":"Anderson CL, Gross AL, Pettigrew C, Vazquez JP, Moghekar A, Oh S et al (2025) Cognitive resilience in preclinical Alzheimer\u2019s disease: Higher NPTX2 and VGF levels are associated with reduced cognitive decline. Neurobiol Aging 156:133\u2013142. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.09.002","journal-title":"Neurobiol Aging"},{"key":"2190_CR20","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1002\/alz.12353","volume":"17","author":"O Libiger","year":"2021","unstructured":"Libiger O, Shaw LM, Watson MH, Nairn AC, Uma\u00f1a KL, Biarnes MC et al (2021) Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer\u2019s disease. Alzheimers Dement 17:1976\u20131987. https:\/\/doi.org\/10.1002\/alz.12353","journal-title":"Alzheimers Dement"},{"issue":"48","key":"2190_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf6935","volume":"7","author":"M-F Xiao","year":"2021","unstructured":"Xiao M-F, Roh S-E, Zhou J, Chien C-C, Lucey BP, Craig MT et al (2021) A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function. Sci Adv 7(48):eabf6935","journal-title":"Sci Adv"},{"key":"2190_CR22","doi-asserted-by":"publisher","first-page":"1380410","DOI":"10.3389\/fpsyt.2024.1380410","volume":"15","author":"M Adamou","year":"2024","unstructured":"Adamou M, Arif M, Asherson P, Cubbin S, Leaver L, Sedgwick-M\u00fcller J et al (2024) The adult ADHD assessment quality assurance standard. Front Psychiatry 15:1380410. https:\/\/doi.org\/10.3389\/fpsyt.2024.1380410","journal-title":"Front Psychiatry"},{"key":"2190_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/10870547241310990","volume":"29","author":"A Kande\u011fer","year":"2025","unstructured":"Kande\u011fer A, G\u00fcler HA, \u00d6zalt\u0131n MS, Bay\u0131rl\u0131 \u00d6, S\u00f6ylemez H, Y\u0131ld\u0131z E et al (2025) Could maladaptive daydreaming delay ADHD diagnosis until adulthood? Clinical characteristics of adults with ADHD based on diagnosis age. J Atten Disord 29:387\u2013396. https:\/\/doi.org\/10.1177\/10870547241310990","journal-title":"J Atten Disord"},{"key":"2190_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S0033291704002892","volume":"35","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E et al (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35:245\u2013256","journal-title":"Psychol Med"},{"key":"2190_CR25","first-page":"78","volume":"10","author":"S Do\u011fan","year":"2009","unstructured":"Do\u011fan S, \u00d6nc\u00fc \u00c7etinkaya B, Sara\u00e7o\u011flu Varol G, K\u00fc\u00e7\u00fckg\u00f6nc\u00fc S (2009) Validity and reliability of the Turkish version of the Adult ADHD Self-Report Scale (ASRS-v1. 1). Alpha Psychiatry 10:78\u201387","journal-title":"Alpha Psychiatry"},{"key":"2190_CR26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1176\/ajp.150.6.885","volume":"150","author":"MF Ward","year":"1993","unstructured":"Ward MF (1993) The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150:885\u2013890","journal-title":"Am J Psychiatry"},{"key":"2190_CR27","first-page":"252","volume":"16","author":"B Oncu","year":"2005","unstructured":"Oncu B, Olmez S, Senturk V (2005) Validity and reliability of the Turkish version of the Wender Utah rating scale for attention-deficit\/hyperactivity disorder in adults. Turk Psikiyatri Derg 16:252\u2013259","journal-title":"Turk Psikiyatri Derg"},{"key":"2190_CR28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1177\/1087054716651927","volume":"23","author":"FD Mowlem","year":"2019","unstructured":"Mowlem FD, Skirrow C, Reid P, Maltezos S, Nijjar SK, Merwood A et al (2019) Validation of the mind excessively wandering scale and the relationship of mind wandering to impairment in adult ADHD. J Atten Disord 23:624\u2013634","journal-title":"J Atten Disord"},{"key":"2190_CR29","first-page":"201","volume":"59","author":"\u015eG Aksoy","year":"2022","unstructured":"Aksoy \u015eG, Aksoy UM, Semerci B (2022) Linguistic equivalence, validity and reliability study of the mind excessively wandering scale. Arch Neuropsychiatry 59:201\u2013209","journal-title":"Arch Neuropsychiatry"},{"key":"2190_CR30","first-page":"280","volume":"8","author":"\u00d6 Aydemir","year":"1997","unstructured":"Aydemir \u00d6, Guvenir T, Kuey L, Kultur S (1997) Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk Psikiyatri Derg 8:280\u2013287","journal-title":"Turk Psikiyatri Derg"},{"key":"2190_CR31","unstructured":"Karaka\u015f S, Erdo\u011fan E, Sak L, Soysal A\u015e, Ulusoy T, Ulusoy \u0130Y, et al (1999) Stroop Test TBAG Form: Standardization for Turkish Culture, Reliability and Validity. J Clin Psy 2:75\u201388"},{"key":"2190_CR32","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1017\/S0033291700038460","volume":"22","author":"S Della Sala","year":"1992","unstructured":"Della Sala S, Laiacona M, Spinnler H, Ubezio C (1992) A cancellation test: its reliability in assessing attentional deficits in alzheimer\u2019s disease. Psychol Med 22:885\u2013901","journal-title":"Psychol Med"},{"key":"2190_CR33","unstructured":"Karaka\u015f S, Eski R, Ba\u015far E (1996) A neuropsychological test battery standardized for Turkish culture: The BILNOT Battery. In: Proceedings of the 32nd National Neurology Congress. Ufuk Publishing, Istanbul, pp 43\u201370"},{"key":"2190_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1080\/13854049308401893","volume":"7","author":"MA Mountain","year":"1993","unstructured":"Mountain MA, Snow WG (1993) Wisconsin card sorting test as a measure of frontal pathology: a review. Clin Neuropsychol 7:108\u2013118","journal-title":"Clin Neuropsychol"},{"key":"2190_CR35","first-page":"61","volume":"8","author":"S Karaka\u015f","year":"2002","unstructured":"Karaka\u015f S (2002) Neuropsychological test for the evaluation of cognitive functions. Turk J Neurol 8:61\u201369","journal-title":"Turk J Neurol"},{"key":"2190_CR36","volume-title":"Judgment of Line Orientation","author":"AL Benton","year":"1983","unstructured":"Benton AL, Varney N, Hamsher KD (1983) Judgment of Line Orientation. University of Iowa, Iowa City"},{"key":"2190_CR37","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"2013","unstructured":"Cohen J (2013) Statistical power analysis for the behavioral sciences. Routledge, New York"},{"key":"2190_CR38","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1096\/fj.201902257RR","volume":"34","author":"P F\u00f6rstner","year":"2020","unstructured":"F\u00f6rstner P, Kn\u00f6ll B (2020) Interference of neuronal activity-mediated gene expression through serum response factor deletion enhances mortality and hyperactivity after traumatic brain injury. FASEB J 34:3855\u20133873","journal-title":"FASEB J"},{"key":"2190_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00767","volume":"9","author":"CT Li","year":"2019","unstructured":"Li CT, Yang KC, Lin WC (2019) Glutamatergic dysfunction and glutamatergic compounds for major psychiatric disorders: evidence from clinical neuroimaging studies. Front Psychiatry 9:422826","journal-title":"Front Psychiatry"},{"key":"2190_CR40","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.1038\/tp.2016.273","volume":"7","author":"J Naaijen","year":"2017","unstructured":"Naaijen J, Bralten J, Poelmans G, Glennon J, Franke B, Buitelaar J (2017) Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism. Transl Psychiatry 7:e999","journal-title":"Transl Psychiatry"},{"key":"2190_CR41","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00406-024-01643-0","volume":"275","author":"MV Vidor","year":"2025","unstructured":"Vidor MV, Vitola ES, Bandeira CE, Martins AR, de Araujo Tavares ME, Cupertino RB et al (2025) Glutamate imbalance in key structure of the default mode network in adults with attention-deficit\/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 275:1863\u20131871. https:\/\/doi.org\/10.1007\/s00406-024-01643-0","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2190_CR42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fnagi.2019.00132","volume":"11","author":"A Soldan","year":"2019","unstructured":"Soldan A, Moghekar A, Walker KA, Pettigrew C, Hou X, Lu H et al (2019) Resting-state functional connectivity is associated with cerebrospinal fluid levels of the synaptic protein NPTX2 in non-demented older adults. Front Aging Neurosci 11:132","journal-title":"Front Aging Neurosci"},{"key":"2190_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ajmg.b.32726","volume":"180","author":"X Huang","year":"2019","unstructured":"Huang X, Wang M, Zhang Q, Chen X, Wu J (2019) The role of glutamate receptors in attention-deficit\/hyperactivity disorder: from physiology to disease. Am J Med Genet B Neuropsychiatr Genet 180:272\u2013286","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2190_CR44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.euroneuro.2017.07.002","volume":"27","author":"M Manchia","year":"2017","unstructured":"Manchia M, Piras IS, Huentelman MJ, Pinna F, Zai CC, Kennedy JL et al (2017) Pattern of gene expression in different stages of schizophrenia: down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets. Eur Neuropsychopharmacol 27:1054\u20131063","journal-title":"Eur Neuropsychopharmacol"},{"key":"2190_CR45","doi-asserted-by":"publisher","first-page":"e23798","DOI":"10.7554\/eLife.23798","volume":"6","author":"MF Xiao","year":"2017","unstructured":"Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y et al (2017) NPTX2 and cognitive dysfunction in alzheimer\u2019s disease. Elife 6:e23798","journal-title":"Elife"},{"key":"2190_CR46","first-page":"47","volume":"16","author":"AF Arnsten","year":"2009","unstructured":"Arnsten AF, Berridge CW, McCracken JT (2009) The neurobiological basis of attention-deficit\/hyperactivity disorder. Prim Psychiatry 16:47\u201354","journal-title":"Prim Psychiatry"},{"key":"2190_CR47","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3934\/Neuroscience.2024031","volume":"11","author":"U Ansari","year":"2024","unstructured":"Ansari U, Wen J, Syed B, Nadora D, Sedighi R, Nadora D et al (2024) Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: a literature review. AIMS Neurosci 11:505\u2013519","journal-title":"AIMS Neurosci"},{"key":"2190_CR48","doi-asserted-by":"publisher","first-page":"D1271","DOI":"10.1093\/nar\/gkx1029","volume":"46","author":"T Schmidt","year":"2018","unstructured":"Schmidt T, Samaras P, Frejno M, Gessulat S, Barnert M, Kienegger H et al (2018) ProteomicsDB. Nucleic Acids Res 46:D1271\u2013D1281","journal-title":"Nucleic Acids Res"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02190-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-02190-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02190-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:01:19Z","timestamp":1780538479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-02190-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2190"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-02190-x","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval was obtained from the Local Ethics Committee of Sel\u00e7uk University Faculty of Medicine (Approval No: 2023\/495). Written informed consent was obtained from all participants prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}